You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
|
|---|---|
| Published in |
Clinical Gastroenterology and Hepatology, August 2014
|
| DOI | 10.1016/j.cgh.2014.07.055 |
| Pubmed ID | |
| Authors |
Maria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, Anthony de Buck van Overstraeten, Thomas Billiet, Filip Baert, Albert Wolthuis, Gert Van Assche, Maja Noman, Ilse Hoffman, Andre D’Hoore, Ann Gils, Paul Rutgeerts, Marc Ferrante |
| Abstract |
Infliximab is effective for patients with refractory ulcerative colitis (UC), but few factors have been identified that predict long-term outcome of therapy. We aimed to identify a panel of markers associated with outcome of infliximab therapy, to help physicians make personalized treatment decisions. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 33% |
| Ireland | 1 | 17% |
| France | 1 | 17% |
| Canada | 1 | 17% |
| Unknown | 1 | 17% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Science communicators (journalists, bloggers, editors) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Unknown | 117 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 16% |
| Other | 13 | 11% |
| Student > Ph. D. Student | 12 | 10% |
| Student > Postgraduate | 11 | 9% |
| Student > Master | 11 | 9% |
| Other | 28 | 24% |
| Unknown | 24 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 65 | 55% |
| Agricultural and Biological Sciences | 6 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Nursing and Health Professions | 2 | 2% |
| Other | 9 | 8% |
| Unknown | 30 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 60. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2019.
All research outputs
#710,505
of 25,374,647 outputs
Outputs from Clinical Gastroenterology and Hepatology
#227
of 4,672 outputs
Outputs of similar age
#6,712
of 242,447 outputs
Outputs of similar age from Clinical Gastroenterology and Hepatology
#5
of 78 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,672 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.9. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,447 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.